Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-12-05
2006-12-05
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S277000, C546S201000, C546S202000, C546S192000, C546S195000, C546S184000
Reexamination Certificate
active
07144898
ABSTRACT:
The present invention provides compounds of formula (I): which are useful for treating depression, anxiety, and alleviating the symptoms caused by withdrawal or partial withdrawal from the use of tobacco or of nicotine.
REFERENCES:
patent: 3929793 (1975-12-01), Popelak et al.
patent: 4304915 (1981-12-01), Berthold
patent: 5300498 (1994-04-01), Shutske
patent: 5576321 (1996-11-01), Krushinski et al.
patent: 5627196 (1997-05-01), Audia et al.
patent: 5789402 (1998-08-01), Audia et al.
patent: 5912256 (1999-06-01), Koch et al.
patent: 6242450 (2001-06-01), Koch et al.
patent: 025111 (1981-03-01), None
patent: 722941 (1996-07-01), None
patent: 976747 (2000-02-01), None
patent: WO00/06166 (2000-02-01), None
patent: WO00/71517 (2000-11-01), None
Hansen Marvin Martin
He John Xiaoqiang
Honigschmidt Nicholas Allan
Koch Daniel James
Kohn Todd Jonathan
Eli Lilly and Company
Gaylo Paul J.
Hostettler Danica
Johnsen Jason H.
Wilson James O.
LandOfFree
Indole derivatives for the treatment of depression and anxiety does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole derivatives for the treatment of depression and anxiety, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives for the treatment of depression and anxiety will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3707260